Microbiosensor is a medical device company developing disposable point-of-care safety monitors for detecting microbial infection.
Microbiological monitoring is especially important for long-term users of medical devices. Medical device use is one of the highest risk factors for nosocomial infection, affecting nearly 2 million patients and killing approximately 90,000 annually in the US alone. At risk groups include patients with chronic wounds, such as diabetic leg ulcers, or those requiring long-term invasive medical device intervention, such as kidney dialysis patients.
Microbiosensor Ltd is addressing this need for improved infection monitoring head-on, by offering the market unique, robust and inexpensive diagnostic solutions. Our devices provide continuous safety monitoring, enhancing patient care by allowing earlier intervention than is currently possible. This will improve treatment outcomes and ultimately help in the fight against multi-drug resistance, by improving the management of the remaining arsenal of effective antibiotic drugs.
Dr Gordon Barker
Gordon is a co-founder of Microbiosensor Ltd and an experienced entrepreneur / manager with a successful track record of commercialising biotech innovations developed at UK universities. Gordon has helped found and grow a number of university spinout and high-growth technology companies.
Professor Curtis Dobson
Curtis runs the successful Medical Device Biology Group at the University of Manchester and is co-inventor of the Microbiosensor technology platform. He has over ten years experience of managing university spin out companies in various senior roles and is a consultant to several major European and US medical device companies.
Dr Nishal Govindji-Bhatt
Nishal is an experienced medical and applied microbiologist with a strong background in commercial research for biotech SMEs. She has responsibility for managing all of Microbiosensor’s R&D programs, from concept through to the working prototype stage.
Dr Duncan Henderson
Product Development Manager
Duncan is an experienced project manager, having managed start-up biotech ventures as well as R&D programs at a global pharmaceutical firm. Duncan has direct responsibility for bringing our most advanced product to market – a diagnostic device for peritoneal dialysis patients, scheduled for launch in 2017.
Prof Phil Morgan | Prof Peter Fielden
Dr Andrew McBain | Dr Carole Maldonado-Codina
Dr Frank Bowling | Dr Anand Vardhan | Prof Nicola Tirelli
Microbiosensor is delighted to have an experienced and multidisciplinary scientific advisory board, with expertise covering microbiology, instrumentation science, micromanufacturing, biomaterials, medical device clinical trials and clinical practice.